PT  - JOURNAL ARTICLE
AU  - Bayati, Mohamed
AU  - Hsieh, Hsin-Yeh
AU  - Hsu, Shu-Yu
AU  - Li, Chenhui
AU  - Rogers, Elizabeth
AU  - Belenchia, Anthony
AU  - Zemmer, Sally A.
AU  - Blanc, Todd
AU  - LePage, Cindy
AU  - Klutts, Jessica
AU  - Reynolds, Melissa
AU  - Semkiw, Elizabeth
AU  - Johnson, Hwei-Yiing
AU  - Foley, Trevor
AU  - Wieberg, Chris G.
AU  - Wenzel, Jeff
AU  - Lyddon, Terri
AU  - LePique, Mary
AU  - Rushford, Clayton
AU  - Salcedo, Braxton
AU  - Young, Kara
AU  - Graham, Madalyn
AU  - Suarez, Reinier
AU  - Ford, Anarose
AU  - Lei, Zhentian
AU  - Sumner, Lloyd
AU  - Mooney, Brian P.
AU  - Wei, Xing
AU  - Greenlief, C. Michael
AU  - Johnson, Marc C.
AU  - Lin, Chung-Ho
TI  - Identification and Quantification of Bioactive Compounds Suppressing SARS-CoV-2 Signals in Wastewater-based Epidemiology Surveillance
AID  - 10.1101/2022.03.09.22272155
DP  - 2022 Jan 01
TA  - medRxiv
PG  - 2022.03.09.22272155
4099  - http://medrxiv.org/content/early/2022/03/12/2022.03.09.22272155.short
4100  - http://medrxiv.org/content/early/2022/03/12/2022.03.09.22272155.full
AB  - Recent SARS-CoV-2 wastewater-based epidemiology (WBE) surveillance have documented a positive correlation between the number of COVID-19 patients in a sewershed and the level of viral genetic material in the wastewater. Efforts have been made to use the wastewater SARS-CoV-2 viral load to predict the infected population within each sewershed using a multivariable regression approach. However, reported clear and sustained variability in SARS-CoV-2 viral load among treatment facilities receiving industrial wastewater have made clinical prediction challenging. Several classes of molecules released by regional industries and manufacturing facilities, particularly the food processing industry, can significantly suppress the SARS-CoV-2 signals in wastewater by breaking down the lipid-bilayer of the membranes. Therefore, a systematic ranking process in conjugation with metabolomic analysis was developed to identify the wastewater treatment facilities exhibiting SARS-CoV-2 suppression and identify and quantify the chemicals suppressing the SARS-COV-2 signals. By ranking the viral load per diagnosed case among the sewersheds, we successfully identified the wastewater treatment facilities in Missouri, USA that exhibit SARS-CoV-2 suppression (significantly lower than 5 × 1011 gene copies/reported case) and determined their suppression rates. Through both untargeted global chemical profiling and targeted analysis of wastewater samples, 40 compounds were identified as candidates of SARS-CoV-2 signal suppression. Among these compounds, 14 had higher concentrations in wastewater treatment facilities that exhibited SARS-CoV-2 signal suppression compared to the unsuppressed control facilities. Stepwise regression analyses indicated that 4-nonylphenol, palmitelaidic acid, sodium oleate, and polyethylene glycol dioleate are positively correlated with SARS-CoV-2 signal suppression rates. Suppression activities were further confirmed by incubation studies, and the suppression kinetics for each bioactive compound were determined. According to the results of these experiments, bioactive molecules in wastewater can significantly reduce the stability of SARS-CoV-2 genetic marker signals. Based on the concentrations of these chemical suppressors, a correction factor could be developed to achieve more reliable and unbiased surveillance results for wastewater treatment facilities that receive wastewater from similar industries.Competing Interest StatementThe authors have declared no competing interest.Funding StatementFunding for the project was administered by the Missouri Department of Health and Senior 377 Services (DHSS). This project was supported by funding from the Centers for Disease control and 378 the National Institutes of Health grant U01DA053893-01Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors